Brief: Titan Pharmaceuticals Announces FDA Clearance Of IND Application For Nalmefene Implant
05/07/2022 13:05
July 5 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND
APPLICATION
FOR NALMEFENE IMPLANT
Source text for Eikon: ID:nPn8s2dvJa
Further company coverage: TTNP.O
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.